These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37081955)

  • 1. Corrigendum: Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020-2021: Impact on medication adherence.
    Zhang M; Wang G; Najmi H; Yaqoob A; Li T; Xia Y; Ye J; Hou S; Xiao Y; Zhou L; Li Y
    Front Public Health; 2023; 11():1191444. PubMed ID: 37081955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020-2021: Impact on medication adherence.
    Zhang M; Wang G; Najmi H; Yaqoob A; Li T; Xia Y; Ye J; Hou S; Xiao Y; Zhou L; Li Y
    Front Public Health; 2023; 11():1033532. PubMed ID: 36935730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Protecting Healthcare Workers Amid the COVID-19 Crisis: A Safety Protocol in Wuhan.
    Liu Y; Yang S; Hung M; Tong W; Liu Y
    Front Public Health; 2021; 9():660323. PubMed ID: 33763403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Epidemiological, clinical, and laboratory features of patients infected with
    Li Y; Liu T; Shi C; Wang B; Li T; Huang Y; Xu Y; Tang L
    Front Public Health; 2022; 10():1054878. PubMed ID: 36411858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: JTrack: A Digital Biomarker Platform for Remote Monitoring of Daily-Life Behaviour in Health and Disease.
    Sahandi Far M; Stolz M; Fischer JM; Eickhoff SB; Dukart J
    Front Public Health; 2022; 10():893531. PubMed ID: 35480570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China.
    Wang N; Zhang H; Zhou Y; Jiang H; Dai B; Sun M; Li Y; Kinter A; Huang F
    BMC Infect Dis; 2019 Oct; 19(1):844. PubMed ID: 31615433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.
    Liu X; Thompson J; Dong H; Sweeney S; Li X; Yuan Y; Wang X; He W; Thomas B; Xu C; Hu D; Vassall A; Huan S; Zhang H; Jiang S; Fielding K; Zhao Y
    Lancet Glob Health; 2023 May; 11(5):e693-e703. PubMed ID: 37061308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China.
    Liu J; Cao L; Wu J
    Front Public Health; 2022; 10():1059495. PubMed ID: 36438279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.
    Ridho A; Alfian SD; van Boven JFM; Levita J; Yalcin EA; Le L; Alffenaar JW; Hak E; Abdulah R; Pradipta IS
    J Med Internet Res; 2022 Feb; 24(2):e33062. PubMed ID: 35195534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods.
    Patel D; Berger CA; Kityamuwesi A; Ggita J; Kunihira Tinka L; Turimumahoro P; Feler J; Chehab L; Chen AZ; Gupta N; Turyahabwe S; Katamba A; Cattamanchi A; Sammann A
    JMIR Form Res; 2020 Dec; 4(12):e19270. PubMed ID: 33289494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: What "family affair?" domestic violence awareness in China.
    Su Z; McDonnell D; Cheshmehzangi A; Ahmad J; Chen H; Šegalo S; Cai Y
    Front Public Health; 2022; 10():1122931. PubMed ID: 36684916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: What "Family Affair?" domestic violence awareness in China.
    Su Z; McDonnell D; Cheshmehzangi A; Ahmad J; Chen H; Šegalo S; Cai Y
    Front Public Health; 2022; 10():990348. PubMed ID: 35968427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030.
    Shao B; Yang W; Cao Q
    Front Public Health; 2022; 10():1083211. PubMed ID: 36530672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Delayed diagnosis and treatment of cancer patients during the COVID-19 pandemic in Henan, China: An interrupted time series analysis.
    Liu C; Piao H; Zhang T; Yang D; Li X; Tang X
    Front Public Health; 2023; 11():1164116. PubMed ID: 36926179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model.
    Sazali MF; Rahim SSSA; Mohammad AH; Kadir F; Payus AO; Avoi R; Jeffree MS; Omar A; Ibrahim MY; Atil A; Tuah NM; Dapari R; Lansing MG; Rahim AAA; Azhar ZI
    Tuberc Respir Dis (Seoul); 2023 Apr; 86(2):82-93. PubMed ID: 36597583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Gender differences in tuberculosis incidence rates-A pooled analysis of data from seven high-income countries by age group and time period.
    Peer V; Schwartz N; Green MS
    Front Public Health; 2023; 11():1157235. PubMed ID: 36895682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Knowledge, Attitude, and Practice Survey of COVID-19 Among Healthcare Students During the COVID-19 Outbreak in China: An Online Cross-Sectional Survey.
    Zhang J; Yin Y; Dean J; Zhang X; Zhang Y; Wang J; Zhang Y
    Front Public Health; 2021; 9():829550. PubMed ID: 35071177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Unmet healthcare needs predict frailty onset in the middle-aged and older population in China: A prospective cohort analysis.
    Li J; Wu D; Li H; Chen J
    Front Public Health; 2023; 11():1185209. PubMed ID: 37033056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Marconi VC
    BMC Med; 2022 Sep; 20(1):310. PubMed ID: 36167528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
    Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
    BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.